COMP <GO>
NIKI vs UCAR // OPERATING MARGIN
Niki BioSolutions Inc. (NASDAQ) VS. U Power Limited (Class A) (NASDAQ) • 15-METRIC TALLY: NIKI 2
— UCAR 2
■ METRIC PARITY
LAST: $1.96 (+1.88%) • MKT CAP: $5.7M
operating-margins
—
LAST: $2.85 (-5.00%) • MKT CAP: $5.1M
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NIKI VS. UCAR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NIKI | UCAR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 36.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -5.90% | -18.50% | +12.60 | NIKI | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -3.60% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 2/9 | -1.00 | UCAR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 21.0 | 31.8 | -10.82 | UCAR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.7M | $5.1M | $689.4K | NIKI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NIKI REV | UCAR REV | NIKI GROSS % | UCAR GROSS % | NIKI FCF | UCAR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $5.9M | — | 36.3% | -$1.8M | -$10.0M |
| FY 2024 | $0 | $6.1M | — | 23.6% | -$1.2M | -$10.0M |
| FY 2023 | $431.4K | $2.8M | — | — | -$7.7M | -$9.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NIKI // BETA —
UCAR // BETA —